Skip to main content
. 2013 Dec 12;77(6):1039–1050. doi: 10.1111/bcp.12309

Figure 1.

Figure 1

Whole blood or plasma concentrations (means ± SD) of voclosporin (VCS) 0.4 mg kg−1 every 12 h (Q12H) alone and with ketoconazole 400 mg once daily (QD; A); VCS 0.4 mg kg−1 alone and following 10 days of rifampin 600 mg QD (B); midazolam 7.5 mg alone and with VCS 0.4 mg kg−1 Q12H (C1); α-hydroxy-midazolam after administration of midazolam 7.5 mg alone and with VCS 0.4 mg kg−1 Q12H (C2); VCS 0.4 mg kg−1 Q12H alone and with verapamil 80 mg every 8 h (D); and digoxin 0.25 mg QD alone and with VCS 0.4 mg kg−1 Q12H (E). (A) Inline graphic, VCS alone; Inline graphic, VCS + ketoconazole. (B) Inline graphic, VCS alone; Inline graphic, VCS + rifampin. (C1) Inline graphic, midazolam alone; Inline graphic, midazolam + VCS. (C2) Inline graphic, midazolam alone; Inline graphic, midazolam + VCS. (D) Inline graphic, VCS alone; Inline graphic, VCS + verapamil. (E) Inline graphic, digoxin alone; Inline graphic, digoxin + VCS